Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

VTE prophylaxis unaddressed in acutely ill patients

Amin A et al. The biennial summit of the Thrombosis & Hemostasis Societies of North America 2018, Poster 51.

Key clinical point: There is a significant unmet medical need for VTE prophylaxis in the continuum of care of patients hospitalized for acute medical illnesses.

Major finding: Of the overall study population, only 7% received both inpatient and outpatient VTE prophylaxis.

Study details: An analysis of national data from 17,895 acutely ill hospitalized patients.

Disclosures: The study was funded by Portola Pharmaceuticals. The presenter reported having no financial conflicts.

Source: Amin A et al. THSNA 2018, Poster 51.

Read the article.

Citation:

Amin A et al. The biennial summit of the Thrombosis & Hemostasis Societies of North America 2018, Poster 51.